• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form S-8 filed by Cibus Inc.

    6/23/26 5:10:10 PM ET
    $CBUS
    Agricultural Chemicals
    Industrials
    Get the next $CBUS alert in real time by email
    S-8 1 cbus-formsx8xespp.htm S-8 Document


    As filed with the Securities and Exchange Commission on June 23, 2026
    Registration No. 333-      

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    WASHINGTON, D.C. 20549


    FORM S-8
    REGISTRATION STATEMENT
    UNDER
    THE SECURITIES ACT OF 1933


    Cibus, Inc.
    (Exact name of registrant as specified in its charter)

    Delaware
    (State or other jurisdiction of incorporation or organization)
    27-1967997
    (I.R.S. Employer Identification No.)
    6455 Nancy Ridge Drive
    San Diego, CA
    92121
    (Address of Principal Executive Offices)(Zip Code)
    CIBUS, INC. 2025 EMPLOYEE STOCK PURCHASE PLAN
    (Full title of the plan)
    Jason Stokes
    Chief Administrative Officer
    6455 Nancy Ridge Drive
    San Diego, CA 92121
    (Name and address of agent for service)
    (858) 450-0008
    (Telephone number, including area code, of agent for service)
    Copies to:
    Peter E. Devlin
    Erik B. Lundgren
    Jones Day
    250 Vesey Street
    New York, NY 10281
    (212) 326-3939





    Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
    Large accelerated filer
    ☐
    Accelerated filer
    ☐
    Non-accelerated filer
    ☒
    Smaller reporting company
    ☒
    Emerging growth company
    ☐

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐
    PART I

    INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS

    The information specified in Part I of Form S-8 to be contained in the Section 10(a) prospectus is omitted from this Registration Statement in accordance with Rule 428 under the Securities Act of 1933 (the “Securities Act”), and the Introductory Note to Part I of Form S-8. The documents containing the information specified in Part I of Form S-8 will be delivered to participants in the applicable Plans covered by this Registration Statement as specified by Rule 428(b)(1) under the Securities Act.

    PART II
    INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
    Item 3. Incorporation of Documents by Reference
    The following documents filed by Cibus, Inc. (the “Registrant”) with the Securities and Exchange Commission (the “Commission”) are incorporated by reference into this Registration Statement:
    •the Registrant’s Annual Report on Form 10-K for the year ended December 31, 2025 (including the information in Part III incorporated therein by reference from the Registrant’s Definitive Proxy Statement on Schedule 14A for the year ended December 31, 2025);
    •the Registrant’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2026;
    •the Registrant’s Current Reports on Form 8-K filed on January 30, 2026, March 27, 2026, April 10, 2026, June 5, 2026 and June 9, 2026 (in each case, excluding any information furnished and not filed with the Commission); and
    •the description of the Registrant’s Class A Common Stock contained in our Registration Statement on Form 8-A, filed on July 20, 2017, as the description therein has been updated and superseded by the description of securities contained in Exhibit 99.1 to our Current Report on Form 8-K filed with the SEC on June 29, 2023, including any amendments or reports filed for the purpose of updating the description.
    In addition, all other reports and documents subsequently filed by the Registrant pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Securities Exchange Act of 1934 (the “Exchange Act”), prior to the filing of a post-effective amendment to this Registration Statement which indicates that all securities offered have been sold or which deregisters all securities remaining unsold, shall be deemed to be incorporated by reference in this Registration Statement and to be part hereof from the date of filing of such reports or documents.
    Any statement contained herein, or in a document incorporated or deemed to be incorporated by reference herein, shall be deemed to be modified or superseded for purposes of this Registration Statement to the extent that a statement contained in any subsequently filed document that also is deemed to be incorporated by reference herein, modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Registration Statement.




    Item 4. Description of Securities
    Not applicable.
    Item 5. Interests of Named Experts and Counsel
    Not applicable.
    Item 6. Indemnification of Directors and Officers
    Section 145 of the Delaware General Corporation Law (“DGCL”) provides that a corporation may indemnify any person who was or is a party, or is threatened to be made a party, to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative (other than an action by or in the right of the corporation by reason of the fact that he or she is or was a director, officer, employee or agent of the corporation, or is or was serving at the request of the corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise), against expenses (including attorneys’ fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by him or her in connection with such action, suit or proceeding if he or she acted in good faith and in a manner he or she reasonably believed to be in or not opposed to the best interests of the corporation and, with respect to any criminal action or proceeding, had no reasonable cause to believe his or her conduct was unlawful. A similar standard is applicable in the case of derivative actions (i.e., actions by or in the right of the corporation), except that indemnification extends only to expenses, including attorneys’ fees, incurred in connection with the defense or settlement of such action and the statute requires court approval before there can be any indemnification where the person seeking indemnification has been found liable to the corporation.

    Our second amended and restated certificate of incorporation contains provisions that limit the liability of our directors and officers for monetary damages to the fullest extent permitted by the DGCL. Consequently, our directors will not be personally liable to us or our stockholders for monetary damages for breach of fiduciary duty as a director, except liability:

    •for any breach of the director’s duty of loyalty to our company or our stockholders;

    •for any act or omission not in good faith or that involves intentional misconduct or knowing violation of law;

    •under Section 174 of the DGCL regarding unlawful dividends and stock purchases; or

    •for any transaction from which the director derived an improper personal benefit.

    Any amendment to, or repeal of, these provisions will not eliminate or reduce the effect of these provisions in respect of any act, omission or claim that occurred or arose prior to that amendment or repeal. If the DGCL is amended to provide for further limitations on the personal liability of directors or officers of corporations, then the personal liability of our directors and officers will be further limited to the fullest extent permitted by the DGCL.

    In addition, we have entered into indemnification agreements with our current directors and officers containing provisions that are in some respects broader than the specific indemnification provisions contained in the DGCL. These agreements require us to indemnify these individuals to the fullest extent permitted under Delaware law against liability that may arise by reason of their service to us, and to advance expenses incurred as a result of any proceeding against them as to which they could be indemnified. We also intend to enter into indemnification agreements with our future directors and officers.

    We maintain liability insurance policies that indemnify our directors and officers against various liabilities, including certain liabilities under arising under the Securities Act and the Exchange Act, that may be incurred by them in their capacity as such.

    Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers or persons controlling us pursuant to the foregoing provisions, we have been informed that in the opinion of the Commission, such indemnification is against public policy as expressed in the Securities Act and is therefore unenforceable.

    Item 7. Exemption from Registration Claimed
    Not applicable.



    Item 8. Exhibits.
    Exhibit No.
    Description of Exhibit
    4.1
    Second Amended and Restated Certificate of Incorporation (incorporated by reference to Exhibit 3.2 of the Company’s Current Report on Form 8-K filed with the Commission on June 1, 2023).
    4.2
    Amended and Restated Bylaws (incorporated by reference to Exhibit 3.3 of the Company’s Current Report on Form 8-K filed with the Commission on June 1, 2023).
    5.1*
    Opinion of Jones Day.
    23.1*
    Consent of BDO USA, P.C.
    23.2*
    Consent of Jones Day (included in Exhibit 5.1).
    24.1*
    Power of Attorney (included in the signature page to this Registration Statement).
    99.1
    Cibus, Inc. 2025 Employee Stock Purchase Plan (incorporated by reference to Exhibit 10.1 to the Company’s Form 8-K filed with the SEC on May 27, 2025).
    107*
    Filing Fee Table.

    * Filed herewith.

    Item 9. Undertakings
    (a) The undersigned Registrant hereby undertakes:

    (1) To file, during any period in which offers or sales are being made, a post-effective amendment to this Registration Statement:

    (i) to include any prospectus required by Section 10(a)(3) of the Securities Act;

    (ii) to reflect in the prospectus any facts or events arising after the effective date of this Registration Statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in this Registration Statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than a 20% change in the maximum aggregate offering price set forth in the “Calculation of Registration Fee” table in the effective Registration Statement; and

    (iii) to include any material information with respect to the plan of distribution not previously disclosed in this Registration Statement or any material change to such information in this Registration Statement;

    provided, however, that paragraphs (a)(1)(i) and (a)(1)(ii) do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the Commission by the Registrant pursuant to Section 13 or Section 15(d) of the Exchange Act that are incorporated by reference in this Registration Statement.

    (2) That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time will be deemed to be the initial bona fide offering thereof.

    (3) To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.

    (b) The undersigned Registrant hereby undertakes that, for purposes of determining any liability under the Securities Act, each filing of the Registrant’s annual report pursuant to Section 13(a) or Section 15(d) of the Exchange Act (and, where applicable, each filing of an employee benefit plan’s annual report pursuant to Section 15(d) of the Exchange Act) that is incorporated by reference in this Registration Statement will be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time will be deemed to be the initial bona fide offering thereof.




    (c) Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the Registrant pursuant to the foregoing provisions, or otherwise, the Registrant has been advised that in the opinion of the Commission such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director, officer or controlling person of the Registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.




    SIGNATURES
    Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of San Diego, State of California, on June 23, 2026.
    Cibus, Inc.

    By:/s/ Craig Wichner
    Name:Craig Wichner
    Title:Chief Executive Officer
    POWER OF ATTORNEY
    The undersigned directors and officers of Cibus, Inc. hereby appoint each of Craig Wichner and Cornelis (Carlo) Broos as attorneys-in-fact for the undersigned, with full power of substitution for, and in the name, place and stead of the undersigned, to sign and file with the Securities and Exchange Commission under the Securities Act of 1933, any and all amendments (including post-effective amendments) and exhibits to this Registration Statement on Form S-8 and any and all applications and other documents to be filed with the Securities and Exchange Commission pertaining to the registration of the securities covered hereby, with full power and authority to do and perform any and all acts and things whatsoever requisite and necessary or desirable, hereby ratifying and confirming all that said attorney-in-fact, or his substitute or substitutes, may lawfully do or cause to be done by virtue hereof.
    Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated below.
    SignatureTitleDate
    /s/ Craig WichnerChief Executive OfficerJune 23, 2026
    Craig Wichner(Principal Executive Officer)
    /s/ Cornelis (Carlo) BroosChief Financial OfficerJune 23, 2026
    Cornelis (Carlo) Broos(Principal Financial and Accounting Officer)
    /s/ Mark FinnChairman of the Board of DirectorsJune 23, 2026
    Mark Finn
    /s/ Rory RiggsDirectorJune 23, 2026
    Rory Riggs
    /s/ Jean-Pierre LehmannDirectorJune 23, 2026
    Jean-Pierre Lehmann
    /s/ Gerhard PranteDirectorJune 23, 2026
    Gerhard Prante
    /s/ August MorettiDirectorJune 23, 2026
    August Moretti
    /s/ Kimberly A. BoxDirectorJune 23, 2026
    Kimberly A. Box
    /s/ Thomas UrbanDirectorJune 23, 2026
    Thomas Urban

    Get the next $CBUS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CBUS

    DatePrice TargetRatingAnalyst
    7/29/2024$25.00Buy
    Alliance Global Partners
    7/19/2024$22.00Buy
    Canaccord Genuity
    10/9/2023$25.00Buy
    H.C. Wainwright
    7/19/2023$30.00Buy
    Canaccord Genuity
    More analyst ratings

    $CBUS
    SEC Filings

    View All

    SEC Form S-8 filed by Cibus Inc.

    S-8 - Cibus, Inc. (0001705843) (Filer)

    6/23/26 5:10:52 PM ET
    $CBUS
    Agricultural Chemicals
    Industrials

    SEC Form S-8 filed by Cibus Inc.

    S-8 - Cibus, Inc. (0001705843) (Filer)

    6/23/26 5:10:10 PM ET
    $CBUS
    Agricultural Chemicals
    Industrials

    Cibus Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Cibus, Inc. (0001705843) (Filer)

    6/9/26 8:19:15 AM ET
    $CBUS
    Agricultural Chemicals
    Industrials

    $CBUS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Alliance Global Partners initiated coverage on Cibus Global with a new price target

    Alliance Global Partners initiated coverage of Cibus Global with a rating of Buy and set a new price target of $25.00

    7/29/24 7:49:52 AM ET
    $CBUS
    Agricultural Chemicals
    Industrials

    Canaccord Genuity resumed coverage on Cibus Global with a new price target

    Canaccord Genuity resumed coverage of Cibus Global with a rating of Buy and set a new price target of $22.00

    7/19/24 8:34:00 AM ET
    $CBUS
    Agricultural Chemicals
    Industrials

    H.C. Wainwright initiated coverage on Cibus Global with a new price target

    H.C. Wainwright initiated coverage of Cibus Global with a rating of Buy and set a new price target of $25.00

    10/9/23 8:32:05 AM ET
    $CBUS
    Agricultural Chemicals
    Industrials

    $CBUS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Europe Recognizes Nature-Based Plant Improvement, Opening a New Pathway for Cibus

    SAN DIEGO, June 17, 2026 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS) today welcomed a landmark decision by the European Union. For the first time, crops improved without adding foreign DNA will be treated like conventionally bred crops, not like transgenic GMOs. The decision opens a path for European farmers to grow cleaner crops much more productively, including for example by fighting disease and pests with far fewer chemicals, and it validates the approach Cibus has spent nearly 25 years developing. Cibus improves crops the way nature does, only far faster. Starting from a seed company's best existing varieties, Cibus can add several improvements at once, combining valuable traits li

    6/17/26 8:05:00 AM ET
    $CBUS
    Agricultural Chemicals
    Industrials

    Cibus Names Agricultural Biotechnology Leader Craig Wichner as Chief Executive Officer to Accelerate Growth and Value Creation

    SAN DIEGO, June 08, 2026 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS) (the "Company" or "Cibus"), a leading agricultural technology company that develops and licenses plant traits to seed companies, today announced key leadership changes pursuant to the Company's previously announced succession planning strategy. As part of this plan, Craig Wichner, a board member since November 2025, has been appointed as the Company's Chief Executive Officer. Peter Beetham, who has served as the Company's Interim Chief Executive Officer, will continue his role as the Company's President and Chief Operating Officer. Concurrently, both Mr. Wichner and Dr. Beetham resigned from the Cibus Board of Directors

    6/8/26 6:30:00 PM ET
    $CBUS
    Agricultural Chemicals
    Industrials

    Cibus Reports First Quarter Financial Results and Provides Business Update

    SAN DIEGO, May 14, 2026 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS) (the "Company"), a leading agricultural technology company that develops and licenses plant traits to seed companies, today announced its financial results for the quarter ended March 31, 2026, and provided a business update. Management will host a conference call and webcast today at 4:30 p.m. ET. Management Commentary Peter Beetham, Interim Chief Executive Officer of Cibus, commented, "We are pleased to report continued momentum across our priority programs during the first quarter of 2026. We continue to work with our global seed company partners to change the scale and speed of breeding. Our Rice herbicide toleranc

    5/14/26 4:05:00 PM ET
    $CBUS
    Agricultural Chemicals
    Industrials

    $CBUS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CEO Wichner Craig was granted 894,309 shares (SEC Form 4)

    4 - Cibus, Inc. (0001705843) (Issuer)

    6/10/26 2:55:04 PM ET
    $CBUS
    Agricultural Chemicals
    Industrials

    SEC Form 4 filed by Director Finn Mark Terrence

    4 - Cibus, Inc. (0001705843) (Issuer)

    6/4/26 5:50:55 PM ET
    $CBUS
    Agricultural Chemicals
    Industrials

    SEC Form 4 filed by Director Moretti August J

    4 - Cibus, Inc. (0001705843) (Issuer)

    6/4/26 5:47:00 PM ET
    $CBUS
    Agricultural Chemicals
    Industrials

    $CBUS
    Leadership Updates

    Live Leadership Updates

    View All

    Cibus Announces the Election of Thomas Urban to Board of Directors

    SAN DIEGO, April 15, 2026 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS) (the "Company" or "Cibus"), a leading agricultural technology company that develops and licenses plant traits to seed companies, today announced the election of Thomas Urban to its Board of Directors. "We are pleased to welcome Tom to the Cibus Board of Directors," said Mark Finn, Chairman of the Board of Cibus. "As the Company pursues its commercialization initiatives, translating its trait pipeline into revenue producing relationships, Tom's experience building and scaling agribusiness will be highly valuable to our strategic planning and execution." Mr. Urban is the founder of Agribusiness Advisors, a firm he form

    4/15/26 7:00:00 AM ET
    $CBUS
    Agricultural Chemicals
    Industrials

    Cibus Announces the Election of Craig Wichner to Board of Directors

    SAN DIEGO, Nov. 11, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS), a leading agricultural technology company that develops and licenses plant traits to seed companies, today announced the election of Craig Wichner to its Board of Directors. Mr. Wichner will also serve as a member of the Board's current Strategy Committee. "Craig brings an exceptional combination of financial acumen, strategic discipline, and industry insight to the Cibus Board," said Mark Finn, Chairman of the Board of Cibus. "As Cibus prepares for anticipated commercial scaling of our trait platform, Craig's expertise in sustainable growth and capital strategy in agriculture will be instrumental in strengthening our

    11/11/25 7:00:00 AM ET
    $CBUS
    Agricultural Chemicals
    Industrials

    Cibus Announces the Election of Kimberly A. Box to Board of Directors

    SAN DIEGO, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ: CBUS), a leading agricultural technology company developing and licensing advanced plant traits that enable higher yields, lower input costs, and more sustainable farming, today announced the election of Kimberly A. Box to its Board of Directors. "Kim brings to Cibus extensive leadership experience in technology and commercialization that will be invaluable as we sharpen our strategic commercialization efforts," said Mark Finn, Cibus Chairman. "Her understanding of market dynamics and experience in guiding innovation into scalable businesses will strengthen our strategic governance as we continue to drive long-term value c

    9/25/25 4:05:00 PM ET
    $CBUS
    $MGRC
    Agricultural Chemicals
    Industrials
    Diversified Commercial Services
    Consumer Discretionary

    $CBUS
    Financials

    Live finance-specific insights

    View All

    Cibus to Report First Quarter 2026 Financial Results on May 14, 2026 After the Market Close and Host Conference Call

    SAN DIEGO, April 30, 2026 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS), a leading agricultural technology company that develops and licenses plant traits to seed companies, today announced that the company will report first quarter 2026 financial results on Thursday, May 14, 2026. Cibus' management team will host a conference call and audio webcast at 4:30 p.m. ET on that day to discuss the financial results and other company updates. Title: Cibus, Inc. First Quarter 2026 Results Conference Call Event Date: Thursday, May 14, 2026         Time: 4:30 p.m. ET         Participant Numbers: +1-800-274-8461 (U.S.), +1-203-518-9814 (International)The conference ID "CIBUS" or 24287 will be requir

    4/30/26 4:05:00 PM ET
    $CBUS
    Agricultural Chemicals
    Industrials

    Cibus to Report Fourth Quarter 2025 Financial Results on March 17, 2026 After the Market Close and Host Conference Call

    SAN DIEGO, March 03, 2026 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS), a leading agricultural technology company that develops and licenses plant traits to seed companies, today announced that the company will report fourth quarter 2025 financial results on Tuesday, March 17, 2026. Cibus' management team will host a conference call and audio webcast at 4:30 p.m. ET on that day to discuss the financial results and other company updates. Title: Cibus, Inc. Fourth Quarter 2025 Results Conference Call Event Date: Tuesday, March 17, 2026Time: 4:30 p.m. ETParticipant Numbers: +1-800-343-5172 (U.S.), +1-203-518-9856 (International)The conference ID "CIBUS" or 24287 will be required for entryEv

    3/3/26 4:05:00 PM ET
    $CBUS
    Agricultural Chemicals
    Industrials

    Cibus Reports Third Quarter Financial Results and Provides Year-to-Date Business Update for 2025

    With the addition of Centro Internacional de Agricultura Tropical (CIAT) in the quarter, Cibus now has 5 LATAM Rice customers as momentum continues toward achieving 2027 targeted initial LATAM Rice revenue On track to deliver HT traits to Latin American customer in Q4 2025 with field trials expected to commence by year end Engaged strategic growth advisory firm AgVayā to introduce Indian Rice growers to new solutions to scale crop productivity through advanced gene editing Successfully completed pre-commercial pilot runs for certain biofragrance products; commercial expansion targeted for 2026 Positive field trial results for HT2 in Canola in North America; HT2 and Sclerotinia resistance

    11/13/25 4:05:00 PM ET
    $CBUS
    Agricultural Chemicals
    Industrials